Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells-Reference-Cited by-同舟云学术

Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells

Published:2024-01 Issue: Volume:104 Page:102799
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Parducci Natália Sudan,Garnique Anali Del Milagro Bernabe,Lima Keli,Carlos Jorge Antonio Elias Godoy,Fonseca Natasha Peixoto,de Miranda Lívia Bassani Lins,de Almeida Bruna Oliveira,Rego Eduardo Magalhães,Traina Fabiola,Machado-Neto João Agostinho

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference28 articles.

1. Hematopoiesis;Rieger;Cold Spring Harb. Perspect. Biol.,2012

2. Hematopoiesis: an evolving paradigm for stem cell biology;Orkin;Cell,2008

3. The myeloproliferative disorders;Campbell;N. Engl. J. Med.,2006

4. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data;Arber;Blood,2022

5. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia;Ouyang;Oncotarget,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management;American Journal of Hematology;2024-04-21